Skip to main content

Read more about our corporate brand here.

Search
Reports

The Future of Healthtech

Jennifer Friel Goldstein, Dennis He, Nina Kandilian, Alex Lennox-Miller, Anjalika Komatireddy, Raysa Bousleiman

Key takeaways

Healthtech investment is shifting dramatically. Provider operations now capture 44% of healthtech funding, surpassing alternative care as AI-driven solutions transform administrative and clinical workflows. M&A deals dominate exit strategies, while AI valuations climb to 2021 highs.

 

44%

Of healthtech investment dollars are going to provider operations

If the pace of investment holds, provider ops will have its biggest year ever.

32

Number of M&A deals in provider ops in 2024

The second most active subsector, alternative care, had only 11.

~42%

Boost in seed-stage AI valuations since 2021

AI valuations are growing across the board, but most of all for seed and Series A companies.

Read the full Future of Healthtech report

Get an inside look at the forces driving the sector’s significant growth.

The data

Drawing on over 40 years of expertise, our new healthtech report analyzes the key factors driving healthtech to capture its largest share of healthcare VC investment since mid-2022, particularly in AI-driven provider operations.

INVESTMENT SPENDING

Alternative care loses its crown

Provider operations have taken the lead in healthtech investments, outpacing alternative care and marking a shift from a clinical to an administrative focus.

Provider ops is attracting more VC due to stronger business cases, clear ROI and AI-driven growth.

Percentage of Healthtech VC Spending chart Source: Pitchbook Data, Inc. and SVB proprietary data
EXITS

In provider ops, consolidation drives exit activity

As IPOs have struggled, consolidation through mergers and acquisition has become the dominant exit plan.

Strategic investors and private equity have stepped in to provide liquidity, largely through roll-ups and platform building.

Consolidation Among Providers Operations chart Notes: Exit counts vary from last year’s report due to a switch to a new database. M&A deals are as of 8/31/2025. Source: Pitchbook Data Inc. and SVB proprietary data
VALUATIONS

An AI bubble inflates

Median valuations of AI companies , especially in the early stages, are passing past 2021 highs.

As the AI bubble gets bigger, more experienced healthcare investors are stepping back.

Median Pre-Money Valuation chart Source: JAMA Health Forum, PitchBook Data Inc., and SVB analysis.

Our insights into the healthtech innovation economy

Learn why healthtech is having its biggest year since at least 2021.

More about the authors

Jennifer Friel Goldstein

Jennifer Friel Goldstein

Head of Relationship Management

Dennis He

Dennis He

Managing Director, Life Science and Healthcare

Nina Kandilian

Nina Kandilian

Director

Alex Lennox-Miller

Alex Lennox-Miller

Lead Research Analyst, Market Insights

Anjalika Komatireddy

Anjalika Komatireddy

Raysa Bousleiman

Raysa Bousleiman


Explore other reports

The Future of Climate Tech Reports
Read Report Report

The Future of Climate Tech

Apr 15, 2026

Jordan Kanis, Eli Oftedal, Josh Pherigo, Andrew Pardo

50 BY 2050 Reports
Read Report Report

50 BY 2050

Jordan Kanis, Joshua Posamentier, Eliza Cushman, Marianne Wu, Hilla Watkins

The State of Corporate Venture Capital 2026 Reports
Read Report Report

The State of Corporate Venture Capital 2026

Mark Gallagher, Patrick Eggen, Mikey Kalis, Emma Eschweiler, Abbie Wolf, Anjalika Komatireddy, Eli Oftedal, Jake Ledbetter


This material is for informational purposes only and is not intended to be an offer, specific investment strategy, recommendation, or solicitation to purchase or sell any security or insurance product, and should not be construed as legal, tax, or accounting advice. Please consult with your legal or tax advisor regarding the particular facts and circumstances of your situation prior to making any financial decision. While we believe that the information presented is from reliable sources, we do not represent, warrant, or guarantee that it is accurate or complete.

All third-party trademarks referenced by First Citizens Bank remain the property of their respective owners. First Citizens Bank’s use of third-party trademarks does not indicate any relationship, sponsorship or endorsement between First Citizens Bank and the owners of these trademarks. All references by First Citizens Bank to third-party trademarks are to identify the corresponding third-party goods and services and intended to constitute nominative fair use under applicable trademark laws.

All credit products and loans provided by First-Citizens Bank & Trust Company are subject to underwriting, credit, and collateral approval. Financing availability may vary by state. Restrictions may apply. All information contained herein is for informational purposes only and no guarantee is expressed or implied. Rates, terms, programs, and underwriting policies are subject to change without notice. This is not a commitment to lend. Terms and conditions apply. NMLSR ID 503941
Bank deposit products are offered by First-Citizens Bank & Trust Company. Member FDIC and an Equal Housing Lender.

Investment and insurance products are not a deposit, not FDIC-insured, not guaranteed by First Citizens, not insured by any federal government agency and may lose value.

Back to top
You are now leaving First Citizens Innovation Banking

You will be directed to a different website or mobile app that has its own terms of use, visitor agreement, security and privacy policies. First Citizens Innovation Banking is not responsible for (and does not provide) any products, services or content at the third party site or app, except for the products and services that carry the First Citizens Innovation Banking name.